Product Information
Name:MK 8318
Brand:Biosynth
Description:MK-8318 is a small molecule that binds to and modulates the activity of β-adrenergic receptors, which are involved in asthma therapy. The drug is orally administered and has shown efficacy in asthma patients with symptoms of bronchoconstriction. It also has been shown to be effective in animal models of asthma. MK-8318 acts as an allosteric agonist at the β2 receptor subtype and may have potential for use in other diseases such as diabetes mellitus, where it may decrease glucose levels by increasing insulin release from pancreatic cells.The drug was first synthesized by Merck Research Laboratories in 2006 and has been used clinically as a research tool since then.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:534.5 g/mol
Formula:C27H26F4N2O5
Purity:Min. 95%
Technical inquiry about: MK 8318
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.